Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-25 @ 2:51 AM
NCT ID:
NCT05516433
Eligibility Criteria:
Inclusion Criteria:
* Patient ≥ 18 years old
* Patient hospitalized in the intensive care unit of the Groupe Hospitalier Paris Saint-Joseph or the Avicenne Hospital
* Patient with an infection requiring probabilistic or documented treatment with a carbapenem (imipenem or meropenem)
* French speaking patient
* Patient or relative able to give his or her non-objection
Exclusion Criteria:
* Patients with a carbapenem allergy
* Pregnant or breastfeeding woman
* Patient under guardianship or curatorship
* Patient deprived of liberty
* Patient under court protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05516433
Study Brief:
Protocol Section:
NCT05516433